ood morning, everyone, and how are you today? We are doing just fine, thank you, despite a spot of rain descending on the Pharmalot campus. After all, as the Morning Mayor taught us, “Every brand new day should be unwrapped like a precious gift.” So while you tug on the ribbon, please join us for a cup of stimulation. As always, here are some tidbits. Hope you conquer the world and please do keep in touch …

So how did Dr. Scott Gottlieb, who has been nominated to head the Food and Drug Administration, do during his Senate testimony? By most accounts, he parried questions deftly and looks to win the job, especially since he appears to be a more mainstream choice compared to some other names that were floated. But brand-name drug makers likely noted some warning signs as he indicated he favors steps to speed approvals of generics and biosimilars.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Recommended Stories

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.